R
Arcus Biosciences D
D
RCUS
8.64000
USD
0.13
(1.47%)
مغلق
حجم التداول
23,924
الربح لكل سهم
-5
العائد الربحي
-
P/E
-2
حجم السوق
914,847,592
الأخبار المقالات
العنوان: Arcus Biosciences
القطاع: Healthcare
الصناعة: Biotechnology
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.